0001209191-18-019742.txt : 20180314 0001209191-18-019742.hdr.sgml : 20180314 20180314211137 ACCESSION NUMBER: 0001209191-18-019742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180312 FILED AS OF DATE: 20180314 DATE AS OF CHANGE: 20180314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tucker Sean CENTRAL INDEX KEY: 0001652204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 18690872 MAIL ADDRESS: STREET 1: 385 OYSTER POINT BLVD., SUITE 9A CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxart, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 290 UTAH AVE., SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 550-3500 MAIL ADDRESS: STREET 1: 290 UTAH AVE., SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Aviragen Therapeutics, Inc. DATE OF NAME CHANGE: 20160413 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-12 0 0000072444 Vaxart, Inc. VXRT 0001652204 Tucker Sean 395 OYSTER POINT BLVD, SUITE 405 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Common Stock 2018-03-12 4 M 0 2013 6.49 A 47653 D Common Stock 9060 I By spouse Common Stock 25388 I By joint trust with Frances Chang and Sean Tucker Stock Option (right to buy) 6.49 2018-03-12 4 M 0 2013 0.00 D 2018-03-13 Common Stock 2013 0 D The option is fully vested. /s/ John T. McKenna, Attorney-in-Fact 2018-03-14